Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-03-03 @ 5:30 PM
Study NCT ID:
NCT02478320
Status:
TERMINATED
Last Update Posted:
2023-07-17
First Post:
2015-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-19
First Submit QC Date:
None
Study First Post Date:
2015-06-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-10
Results First Submit QC Date:
None
Results First Post Date:
2023-07-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-11
Last Update Post Date:
2023-07-17
Last Update Post Date Type:
ACTUAL